Your browser doesn't support javascript.
loading
Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors.
Kobayashi, Noritoshi; Takano, Shoko; Ito, Kenichi; Sugiura, Madoka; Ogawa, Matsuyoshi; Takeda, Yuma; Okubo, Naoki; Suzuki, Akihiro; Tokuhisa, Motohiko; Kaneta, Tomohiro; Utsunomiya, Daisuke; Hata, Masaharu; Inoue, Tomio; Hosono, Makoto; Kinuya, Seigo; Ichikawa, Yasushi.
Afiliação
  • Kobayashi N; Department of Oncology, Oncology Division, Yokohama City University Graduate School of Medicine, 3-9, Fuku-ura, Kanazawa-ku, Yokohama, 236-0004, Japan. norikoba@yokohama-cu.ac.jp.
  • Takano S; Department of Radiation Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Ito K; Department of Radiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Sugiura M; Department of Radiation Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Ogawa M; Radiation Department, Yokohama City University Hospital, Yokohama, Japan.
  • Takeda Y; Department of Oncology, Oncology Division, Yokohama City University Graduate School of Medicine, 3-9, Fuku-ura, Kanazawa-ku, Yokohama, 236-0004, Japan.
  • Okubo N; Department of Oncology, Oncology Division, Yokohama City University Graduate School of Medicine, 3-9, Fuku-ura, Kanazawa-ku, Yokohama, 236-0004, Japan.
  • Suzuki A; Department of Oncology, Oncology Division, Yokohama City University Graduate School of Medicine, 3-9, Fuku-ura, Kanazawa-ku, Yokohama, 236-0004, Japan.
  • Tokuhisa M; Department of Oncology, Oncology Division, Yokohama City University Graduate School of Medicine, 3-9, Fuku-ura, Kanazawa-ku, Yokohama, 236-0004, Japan.
  • Kaneta T; Department of Diagnostic Image Analysis, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Utsunomiya D; Department of Radiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Hata M; Department of Radiation Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Inoue T; Advanced Medical Center, Shonan Kamakura General Hospital, Kamakura, Japan.
  • Hosono M; Department of Radiology, Faculty of Medicine, Kindai University, Higashi-osaka, Japan.
  • Kinuya S; The Japanese Society of Nuclear Medicine, Tokyo, Japan.
  • Ichikawa Y; Department of Oncology, Oncology Division, Yokohama City University Graduate School of Medicine, 3-9, Fuku-ura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Ann Nucl Med ; 35(12): 1332-1341, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34533700

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Somatostatina Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Somatostatina Idioma: En Ano de publicação: 2021 Tipo de documento: Article